Cardlytics, Inc.

For the period ended Dec 31, 2025. Filed Mar 4, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 4, 2026

CDLX$1.82-6.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations

(Amounts in thousands, except per share amounts)

	Year Ended December 31,
	2025	2024	2023
Revenue	$233,273	$278,298	$309,204
Costs and expenses:
Partner Share and other third-party costs	102,949	127,761	150,578
Delivery costs	25,711	29,643	28,248
Sales and marketing expense	39,478	52,649	57,425
Research and development expense	39,765	49,607	51,352
General and administrative expense	47,267	56,482	58,810
Acquisition, integration and divestiture costs (benefits)	561	161	(6,313)
Change in contingent consideration	102	210	1,246
Impairment of goodwill and intangible assets	58,843	131,595	70,518
(Gain)/loss on divestiture	(4,831)	—	6,550
Depreciation and amortization expense	25,244	25,689	26,460
Total costs and expenses	335,089	473,797	444,874
Operating loss	(101,816)	(195,499)	(135,670)
Other (expense)/income:
Interest expense, net	(7,919)	(5,553)	(2,336)
Foreign currency gain/(loss)	6,247	(1,269)	3,304
Gain on debt extinguishment	—	13,017	—
Total other (expense)/income	(1,672)	6,195	968
Loss before income taxes	(103,488)	(189,304)	(134,702)
Income tax benefit	—	—	—
Net Loss	(103,488)	(189,304)	(134,702)
Net loss per share, basic and diluted	$(1.95)	$(3.91)	$(3.69)
Weighted-average common shares outstanding, basic and diluted	53,114	48,361	36,488

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.